Biotech 365

Main menu

Skip to primary content
Skip to secondary content
  • Biotech 365
    • Contact
    • Offers
  • Biotech Companies
  • Database researchers
    • BioLeads
  • BioMarketplace
  • Biotech Jobs
  • Biopharma News

Tag Archives: Ysios Capital – private equity for biotech and biopharma companies

Ysios Capital – private equity for biotech and biopharma companies

Posted on 2015-04-08 by Biotech365

Ysios Capital is a leading Spanish independent venture capital firm providing private equity financing to early- and mid-stage biotech and biopharma companies.

Ysios Capital – private equity for biotech and biopharma companies

ysios capital

Continue reading →

Posted in Biotech Companies, Biotech Companies Spain | Tagged AM-Pharma, Aura Biosciences, biotech private equity, biotech private equity financing, biotech venture capital, biotech venture capital firm, Biovex, Cardoz, Carlos Gallardo, CNMV, Cristina Garmendia, CVRx, Endosense, Inbiomotion, Joël Jean-Mairet, Josep Sanfeliu, Julia Salaverría, Kala Pharmaceuticals, Karen Wagner, Laia Crespo, Marc Casellas, MedLumics, Miriam Cortés, Paula Olazábal, Prexton Therapeutics, private equity biopharma companies, private equity biopharma company, private equity biotech companies, private equity biotech company, private equity financing, private equity for biotech and biopharma companies, private equity pharma companies, private equity pharma company, Raúl Martín-Ruiz, Sabirmedical, Spanish Securities Exchange Commission, STAT-Diagnostica, TiGenix, venture capital firm, Ysios Capital, Ysios Capital - private equity for biotech and biopharma companies, ysioscapital
Contact                       Offers                      
Proudly powered by WordPress